Association of diabetes mellitus with long-term prognosis after ablation therapy for patients with hepatocellular carcinoma: A single-center cohort study
Patients with DM exhibited a poorer oncological prognosis than those without DM following ablation for HCC. DM was identified as an independent factor influencing the prognosis of HCC patients after curative ablation. Thus, active therapies targeting DM might enhance oncological outcomes and facilitate individualized treatment decisions.
Authors
- Yue-Hong Sheng
- Jinglei Zhang (ORCID: https://orcid.org/0000-0003-1438-6568)
- Qiang Shen (ORCID: https://orcid.org/0000-0002-9524-2998)
- Neng Wang (ORCID: https://orcid.org/0000-0002-9059-2171)
- Pingsheng Zhou (ORCID: https://orcid.org/0000-0002-6343-9868)
- Guojun Qian (ORCID: https://orcid.org/0000-0002-4558-712X)
- Ming-Da Wang (ORCID: https://orcid.org/0009-0007-4739-9492)
Institutions
- Second Military Medical University (CN)
- Eastern Hepatobiliary Surgery Hospital (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2024-12-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_2708_23
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.37